European Companies Search Engine
Figurative mark Euipotm 3 Dec 2019 European Union Intellectual Property Office (Trade Marks)
History
Text
Trade mark
| Type | Figurative |
| Graphic representation |  |
| Filing number | 018091881 |
| Trade mark status | REGISTERED |
| Nice Classification |
5: Pharmaceutical preparations. 9: Downloadable software in the nature of a mobile application for providing information relating to the treatment of ophthalmic diseases and disorders. 35: Business administration of patient reimbursement programs; business administration of medication reimbursement programs and services; business administration of pharmacy reimbursement programs and services. 41: Educational and training services, namely conducting classes, seminars, workshops, etc. in the field of ophthalmic diseases and disorders; providing online non-downloadable publications in the nature of articles, books and journals in the field of ophthalmic diseases and disorders and the monitoring and management of said diseases and disorders. 42: Providing temporary use of a non-downloadable web application for processing patient information related to ophthalmology. 44: Providing medical information in the field of ophthalmic diseases and disorders; medical services, namely assisting in the observation, monitoring, adherence and compliance of patients to medical treatments; doctor's appointment reminder services pertaining to patient visits to doctors, medical centers and specialists such as ophthalmologists. 45: Organizing and conducting personal and/or emotional support groups in the field of ophthalmology; Social networking services in the field of ophthalmological diseases and disorders and the monitoring and management of said diseases and disorders provided via a website. |
| Filing date | 05/07/2019 |
| Registration date | 30/11/2019 |
| Expiry date | 05/07/2029 |
| Owners |
c/o Novartis Pharma AG Trademark Department CH-4002 Basel Switzerland |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Novartis AG, Basle, Switzerland.